[nomadking]

Originally Posted by 1andrew1

I don't think it's constructive to try and point score here between nations. That approach fails anyway as all the companies concerned contain a wealth of international talent. Astra Zeneca is an Anglo-Swedish company headed up since 2012 by Pascal Soriot, a Frenchman.

---------- Post added at 21:22 ---------- Previous post was at 21:19 ----------


Has it been approved for use in Germany?

Jan 14

FRANKFURT (Reuters) - The head of Germany's vaccine regulator on Thursday described the success rate of AstraZeneca's COVID-19 vaccine as excellent, after some Australian scientists voiced scepticism about its efficacy.
Speaking during an online press briefing, the president of Germany's Paul Ehrlich Institute (PEI), Klaus Cichutek, said there had been some debate over the best usage pattern for the vaccine.
"Still, the efficacy remains outstanding and excellent," he said, citing data.
The AstraZeneca shot, co-developed with Oxford University, was shown in a trial to have efficacy of at least 62%, with Britain's healthcare regulator identifying an efficacy of 80% under a certain administration pattern.

Link

German Health Minister Jens Spahn has said the European Union should monitor its vaccine supply by requiring licensing for vaccine exports, arguing that the EU has sunk hundreds of millions of euros into establishing production capacities in advance.
"It would be a good idea if companies had to obtain a license to export vaccines so that we could monitor which vaccine leaves the EU after having been produced or bottled in Europe," Spahn said in an interview with DW on Monday.
"It is not a matter of being first, it is a matter of being fair," he added.
...
Spahn's comments came as the European Commission said it will require pharmaceutical companies producing COVID-19 vaccines in the EU to register in advance any exports of doses to third countries.
The register is expected to be put into effect this week, and will keep track of which EU producers make vaccine exports and how many doses they ship outside of the bloc.
Under the plan, vaccine makers would also need a license to export doses made in the EU.

The UK ordered doses, long before the EU got its act together. First come, first served.